论文部分内容阅读
目的探讨脑梗死应用辛伐他汀联合抗栓治疗的临床疗效。方法 88例脑梗死患者随机分为两组,对照组给予抗栓治疗,观察组加用辛伐他汀治疗。结果观察组患者平均MBI评分为(59.64±3.61)分,其治疗总有效率为95.45%;对照组患者平均MBI评分为(40.55±2.62)分,其治疗总有效率为79.55%,两组差异有统计学意义(P<0.05)。结论辛伐他汀联合抗栓疗法应用于脑梗死治疗中的临床疗效确切。
Objective To investigate the clinical effect of simvastatin combined with antithrombotic therapy in patients with cerebral infarction. Methods 88 patients with cerebral infarction were randomly divided into two groups, the control group was given antithrombotic therapy, the observation group plus simvastatin treatment. Results The average MBI score of the observation group was (59.64 ± 3.61) points, the total effective rate was 95.45%. The average MBI score of the control group was (40.55 ± 2.62) points, the total effective rate was 79.55% There was statistical significance (P <0.05). Conclusion Simvastatin combined with antithrombotic therapy is effective in the treatment of cerebral infarction.